Stereotaxis (STXS) Cash from Investing Activities (2010 - 2026)
Stereotaxis (STXS) posted quarterly Cash from Investing Activities of -$79000.0 for Q1 2026, down 12.86% quarter-over-quarter from -$70000.0 in Q4 2025.
Stereotaxis (STXS) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Cash from Investing Activities for 14 consecutive years, with -$79000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$79000.0; the TTM figure through Mar 2026 stood at -$151000.0 (changed N/A YoY), while the FY2025 annual figure was -$93000.0, down 225.68% from the prior year.
- Cash from Investing Activities eased to -$79000.0 in Q1 2026 per STXS's latest filing, from -$70000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $20.1 million in Q2 2023 and bottomed at -$20.1 million in Q4 2022.
- Historically, Cash from Investing Activities has averaged -$216545.5 across 5 years, with a median of -$79000.0 in 2026.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities surged 3196.0% — and 2025, when it plunged 3400.0%.
- Stereotaxis' Cash from Investing Activities stood at -$20.1 million in 2022, then soared by 99.95% to -$10000.0 in 2023, then soared by 80.0% to -$2000.0 in 2024, then slumped by 3400.0% to -$70000.0 in 2025, then retreated by 12.86% to -$79000.0 in 2026.
- Business Quant data shows STXS's Cash from Investing Activities at -$79000.0 in Q1 2026, -$70000.0 in Q4 2025, and -$2000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | -79,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79,000.00 |
| Mar 31, 2026 | -79,000.00 |
| Dec 31, 2025 | -70,000.00 |
| Dec 31, 2025 | -70,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Sep 30, 2024 | 98,000.00 |
| Sep 30, 2024 | 98,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Jun 30, 2023 | 20.12 Mn |
| Jun 30, 2023 | 20.12 Mn |
| Mar 31, 2023 | -349,000.00 |
| Mar 31, 2023 | -349,000.00 |
| Dec 31, 2022 | -20.09 Mn |
| Dec 31, 2022 | -20.09 Mn |
| Sep 30, 2022 | -205,000.00 |
| Sep 30, 2022 | -205,000.00 |
| Jun 30, 2022 | -650,000.00 |
| Jun 30, 2022 | -650,000.00 |